Evaluation of serum granulysin as a potential biomarker for nasopharyngeal carcinoma
Authors:
- 1 February 2016
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 454, 72-76
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Serum granulysin as a possible biomarker of natural killer cell neoplasmsBritish Journal of Haematology, 2010
- Granulysin Induces Cathepsin B Release from Lysosomes of Target Tumor Cells to Attack Mitochondria through Processing of Bid Leading to NecroptosisThe Journal of Immunology, 2009
- Biology and clinical relevance of granulysinTissue Antigens, 2009
- Serum granulysin level as a novel prognostic marker in patients with gastric carcinomaJournal of Gastroenterology and Hepatology, 2007
- Complementary activation of peripheral natural killer cell immunity in nasopharyngeal carcinomaCancer Science, 2006
- Analysis of serum granulysin in patients with hematopoietic stem‐cell transplantation: Its usefulness as a marker of graft‐versus‐host reactionAmerican Journal of Hematology, 2006
- Peripheral γδ T‐cell deficit in nasopharyngeal carcinomaInternational Journal of Cancer, 2002
- Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinomaInternational Journal of Cancer, 2001
- An Antimicrobial Activity of Cytolytic T Cells Mediated by GranulysinScience, 1998
- Prospective studies on nasopharyngeal carcinoma in epstein‐barr virus IgA/VCA antibody‐positne persons in Wuzhou city, chinaInternational Journal of Cancer, 1985